CRISPR Patent Outcome Won’t Slow Innovation

CRISPR Patent Outcome Won’t Slow Innovation
forbes

The legal battle over who invented the powerful gene-editing tool isn't likely to dim hopes for better crops and powerful new medical treatments.

Last week a panel of judges at the U.S. Patent and Trademark Office in Alexandria, Virginia, heard arguments as to who should own the rights to the century's biggest biotechnology invention to date, a precise gene-editing system called CRISPR-Cas9 that has the potential to treat serious human genetic disorders and create designer crops that resist drought and pathogens.



Comment
Show comments Hide Comments


Related Articles